Schedule 13D ownership disclosure

LIPELLA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 53630L100

Event date: 2024-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
18.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-24-001449
Form type
SC 13D/A
Filer
Chancellor Michael B
CIK
CIK 1959360
Filed
Aug 19, 2024
Reporting period
Aug 16, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub